Thus, there is no reason to recommend any form of genetic testing in MHT users except for thrombophilia testing (prothrombin G20210A mutation or factor V Leiden mutation) in women with a personal and/or family history of thrombosis [3]. This evidence concerns the gene F5 and deep vein thrombosis.